German Diabetes Center

Quick facts

Marketed products

• Fat/Inflammation effects · Diabetes
  This is a research focus area rather than a specific drug, targeting the reduction of fat accumulation and inflammatory markers associated with metabolic dysfunction.
• fat orally
• intransal insulin

Phase 1 pipeline

• intravenous glucose tolerance test
• Off Metformin
• On Metformin

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• German Diabetes Center portfolio CI brief
• German Diabetes Center pipeline updates RSS